Wilflingseder Doris, Assoz. Prof. Priv.-Doz. Mag.Dr

University / Clinic: Medical University Innsbruck
Institute: Division of Hygiene and Medical Microbiology
 
Research Area: Immunology, Host-pathogen interactions, Cell Biology

Email: doris.wilflingseder@i-med.ac.at
Web: www.i-med.ac.at/hygiene/forschungwilflingsederstartseite.html.en


Research Topic:
Persistent infections such as HIV, hepatitis B and C virus are major causes of mortality world-wide. Dendritic cells (DCs), the sentinels of the immune system, are essential for the generation of a protective antiviral immune response. Nevertheless, they are exploited by the viruses to evade innate and adaptive immunity. Upon entering the body via mucosal surfaces, HIV-1 is spontaneously opsonized with complement fragments due to activating the classical complement pathway even in the absence of specific antibodies. After seroconversion, the virus is additionally coated with specific antibodies. Studies involving the differential opsonization pattern of pathogens are an important issue in scientific research, which is rarely addressed in the literature. Due to addressing various receptors, the opsonization pattern of pathogens has a strong impact on the antigen-presenting capacity of DCs. In our group, we are studying different antigen-presenting cells exposed to opsonized/non-opsonized pathogens and consequently the impact of the opsonization pattern on specific cell functions. Therefore, to mimic the in vivo situation more closely, we are integrating innate (complement) and adaptive (antibodies) humoral immune components in all our experimental set-ups.

Project:
  DC-iphering complement- and Fc-receptor- mediated HIV-1 incorporation in and effects on DC function in search for novel therapeutical targets
details ...

Selected publications:
 
  Posch W, Pfaller K, Lass-Flörl C, Wilflingseder D
The viral make-up makes a world of difference.
AIDS Res Hum Retroviruses. 2014 Jul;30(7):642-3. doi: 10.1089/aid.2014.0061.

  Theurl M, Nairz M, Schroll A, Sonnweber T, Asshoff M, Haschka D, Seifert M, Willenbacher W, Wilflingseder D, Posch W, Murphy A, Witcher D, Theurl I, Weiss G
Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats.
Haematologica. 2014 Sep;99(9):1516-24. doi: 10.3324/haematol.2013.099481. Epub 2014 Jun 3. PubMed PM

  Ehrlenbach S, Rosales A, Posch W, Wilflingseder D, Hermann M, Brockmeyer J, Karch H, Satchell S, Würzner R, Orth-Höller D
Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells.
Infect Immun. 2013 Aug;81(8):2678-85. doi: 10.1128/IAI.01079-12. Epub 2013 May 20. PubMed PMID: 2369

  Posch W, Cardinaud S, Hamimi C, Fletcher A, Mühlbacher A, Loacker K, Eichberger P, Dierich M, Pancino G, Lass-Flörl C, Moris A, Saez-Cirion A, Wilflingseder D
Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes.
J Allergy Clin Immunol. 2012 Dec;130(6):1368-74.e2. doi: 10.1016/j.jaci.2012.08.025. Epub 2012 Oct 1

  Posch W, Piper S, Lindhorst T, Werner B, Fletcher A, Bock H, Lass-Flörl C, Stoiber H, Wilflingseder D
Inhibition of human immunodeficiency virus replication by cell membrane-crossing oligomers.
Mol Med. 2012 Feb 10;18:111-22. doi: 10.2119/molmed.2011.00128. PubMed PMID: 22105607; PubMed Centra

  Bánki Z, Posch W, Ejaz A, Oberhauser V, Willey S, Gassner C, Stoiber H, Dittmer U, Dierich M, Hasenkrug K, Wilflingseder D
Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.
PLoS Pathog. 2010 Apr 29;6(4):e1000891. doi: 10.1371/journal.ppat.1000891. PubMed PMID: 20442876; P

  Falkensammer B, Rubner B, Hiltgartner A, Wilflingseder D, Stahl H, Kuate S, Uberla K, Norley S, Strasak A, Racz P, Stoiber H
Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors.
Retrovirology. 2009 Jun 21;6:60. doi: 10.1186/1742-4690-6-60. PubMed PMID: 19545395; PubMed Central

  Wilflingseder D, Stoiber H
Float on: lipid rafts in the lifecycle of HIV.
Front Biosci. 2007 Jan 1;12:2124-35. Review. PubMed PMID: 17127449.

  Söderholm A, Bánki Z, Wilflingseder D, Gassner C, Zwirner J, López-Trascasa M, Falkensammer B, Dierich M, Stoiber H
HIV-1 induced generation of C5a attracts immature dendriticcells and promotes infection of autologous T cells.
Eur J Immunol. 2007 Aug;37(8):2156-63. PubMed PMID: 17595678.

  Wilflingseder D, Banki Z, Garcia E, Pruenster M, Pfister G, Müllauer B, Nikolic D, Gassner C, Ammann C, Dierich M, Piguet V, Stoiber H
IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells.
J Immunol. 2007 Jun 15;178(12):7840-8. PubMed PMID: 7548622

  Bánki Z, Wilflingseder D, Ammann C, Pruenster M, Müllauer B, Holländer K, Meyer M, Sprinzl G, van Lunzen J, Stellbrink H, Dierich M, Stoiber H
Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells.
J Immunol. 2006 Sep 1;177(5):3469-76. PubMed PMID:16920989.

  Wilflingseder D, Müllauer B, Schramek H, Banki Z, Pruenster M, Dierich M, Stoiber H
HIV-1-induced migration of monocyte-derived dendritic cells is associated with differential activation of MAPK pathways.
J Immunol. 2004 Dec 15;173(12):7497-505. PubMed PMID: 15585876.